Which factors predict the time spent answering queries to a drug information centre?

Pharmacy World and Science

Volumn 32, Issue 6, 2010, Pages 799-804

  Reppe, Linda A ^a,b   Spigset, Olav ^a,c   Schjøtt, Jan ^d,e  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORD UNIVERSITY   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Drug information; Drug Information Centres; Norway; Queries; Time; Workload

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DRUG INFORMATION; EVALUATION RESEARCH; FEMALE; HUMAN; INFORMATION CENTER; MALE; NORWAY; PREDICTION; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; RESPONSE TIME; SCORING SYSTEM; SELF REPORT; SEX DIFFERENCE; TIME MANAGEMENT; WORK EXPERIENCE; WORKING TIME; WORKLOAD;

DRUG INFORMATION SERVICES; FORECASTING; INFORMATION CENTERS; INFORMATION STORAGE AND RETRIEVAL; NORWAY; PHARMACEUTICAL PREPARATIONS; TIME FACTORS; WORKLOAD;

EID: 79952696406     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9440-7     Document Type: Article

References (17)

1. Grace M, Wertheimer AI. Judgmental questions processed by a drug information center. Am J Hosp Pharm. 1975;32(9):903-4.
2. Cardoni AA, Thompson TJ. Impact of drug information services on patient care. Am J Hosp Pharm. 1978;35(10):1233-7.
3. Meinhold JM, Nelson AA Jr, Hutchinson RA. Changes in drug information inquiries following implementation of clinical pharmaceutical services. Am J Hosp Pharm. 1979;36(11):1520-3.
4. Merritt GJ, Garnett WR, Eckel FM. Analysis of a hospital-based information center. Am J Hosp Pharm. 1977;34(1):42-6.
5. Romá E, Planells C, Carrera A, Cercõs AC, Sánchez S, Gallego C. Quality management in drug information. Eur Hosp Pharm. 1995;1(2):61-6.
6. Davies DM, Ashton CH, Rao JG, Rawlins MD, Routledge PA, Savage RL, et al. Comprehensive clinical drug information service: first year's experience. Br Med J. 1977;1(6053):89-90.
7. Morrow NC, D'Arcy PF, Pielou LW. Drug information inquiries - who asks what and where are the answers? J Clin Hosp Pharm. 1984;9(4):321-31.
8. Smith CJ, Sylvia LM. External quality assurance committee for drug information services. Am J Hosp Pharm. 1990;47(4):787-91. (Pubitemid 20144003)
9. Joy ME, Arana CJ, Gallo GR. Use of information sources at a university hospital drug information service. Am J Hosp Pharm. 1986;43(5):1226-9. (Pubitemid 16118200)
10. Regional Drug Information Centres (RELIS). RELIS database (In Norwegian). Oslo/Tromsø/Trondheim/Bergen (Norway). [Updated 2010 Jun 11, cited 2010 Jun 11]. http://www.relis.no/database/.
11. Schjøtt J, Pomp E, Gedde-Dahl A. Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? Eur J Clin Pharmacol. 2002;57(12):897-902.
12. Baxter K. Stockley's Drug Interactions 8th ed. Pharmaceutical Press, London, 2008. ISBN 978-0-85369-754-1.
13. Spigset O. The Drug Interactions Database (DRUID). (In Norwegian) Trondheim, Norway [Updated 2010 Feb, cited 2010 Jun 11]. http://www. interaksjoner.no/.
14. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 5th ed. Lippincott Williams and Wilkins, 2005. ISBN 978-0-7817-7876-3.
15. Källen B, Källen K. Drugs and birth defects. (In Swedish). Läkemedelscentrum, Stockholm, Sweden. [Updated 2009 Oct 6, Cited 2010 Jun 11]. http://www.janusinfo.se/gravreg/.
16. Llerena A, Öhman B, Alván G. References used in a drug information centre. Eur J Clin Pharmacol. 1995;49(1-2):87-9.
17. Widnes SKF, Schjøtt J. Advice on drug safety in pregnancy. Are there differences between commonly used sources of information? Drug Saf. 2008;31(9):799-806.